Cargando…
Proanthocyanidins Should Be a Candidate in the Treatment of Cancer, Cardiovascular Diseases and Lipid Metabolic Disorder
The conventional view of using medicines as routine treatment of an intractable disease is being challenged in the face of extensive and growing evidence that flavonoids in foods, especially proanthocyanidins (PAs), can participate in tackling fatal diseases like cancer, cardiovascular and lipid met...
Autores principales: | Wang, Tsz Ki, Xu, Shaoting, Li, Shuang, Zhang, Yunjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766935/ https://www.ncbi.nlm.nih.gov/pubmed/33339407 http://dx.doi.org/10.3390/molecules25245971 |
Ejemplares similares
-
The Synergistic Effect of Proanthocyanidin and HDAC Inhibitor Inhibit Breast Cancer Cell Growth and Promote Apoptosis
por: Wang, Tsz Ki, et al.
Publicado: (2023) -
Catechins and Proanthocyanidins Involvement in Metabolic Syndrome
por: Patanè, Giuseppe Tancredi, et al.
Publicado: (2023) -
Molecular Insight into Affinities of Gallated and Nongallated Proanthocyanidins Dimers to Lipid Bilayers
por: Zhu, Wei, et al.
Publicado: (2016) -
Role of Adiponectin in Cardiovascular Diseases Related to Glucose and Lipid Metabolism Disorders
por: Han, Wen, et al.
Publicado: (2022) -
Characterization of proanthocyanidin metabolism in pea (Pisum sativum) seeds
por: Ferraro, Kiva, et al.
Publicado: (2014)